货号：UP494495515
| 产品信息 | |
| 产品名称： | MRS1477 |
| 中文名称： | (请以英文为准,中文仅做参考) |
| CAS号： | 212200-21-0 |
| 分子式： | C21H27NO4S |
| 分子量： | 389.51 |
| MDL NO： | MFCD30145651 |
| 标准纯度： | 98+% (UP494495515) |
| 沸点： | - |
| 储存： | (UP494495515) |
| Pubchem ID： | - |
| ACS编号： | - |
| InChIKey： | - |
| Clogp | - |
| 英文别名： | - |
| 中文别名 | - |
Evacetrapib
UP5037330831186486-62-3
RP001 Hydrochloride
UP5188913421306761-53-4
PHenformin hydrochloride
UP134908117834-28-6
Vipadenant
UP573775551442908-10-3
Azathioprine
UP338294024446-86-6
AGI-5198
UP1355726591355326-35-0
SU6656
UP938726811330161-87-0
Ibutamoren Mesylate
UP966423060159752-10-0
Mibefradil dihydrochloride
UP506870129116666-63-8
Meclizine dihydrochloride
UP5101316641104-22-9
Ki16425
UP576201632355025-24-0
Hydroxyzine dihydrochloride
UP7000333342192-20-3
Icatibant
UP961753115130308-48-4
D609
UP11111266783373-60-8
AM095 free acid
UP2874924681228690-36-5
Atosiban
UP42482383490779-69-4
Rasagiline mesylate
UP139594808161735-79-1
Valspodar
UP625059922121584-18-7
Dapagliflozin propanediol hydrate
UP339513932960404-48-2
SB-705498
UP901603540501951-42-4
GSK962040 hydrochloride
UP592456579923565-22-4
SB-674042
UP446229345483313-22-0
Neostigmine Bromide
UP491471374114-80-7
Carboxypeptidase G2 Inhibitor
UP352313789192203-60-4
Saperconazole
UP534409838110588-57-3
E-6446
UP8604225311219925-73-1
Ipragliflozin
UP500860568761423-87-4
Esomeprazole
UP785875233119141-88-7
Sildenafil Mesylate
UP6822148001308285-21-3
FICZ
UP233847001172922-91-7
Dabigatran etexilate mesylate
UP765972946872728-81-9
Balicatib
UP146743346354813-19-7
K-Ras G12C-IN-1
UP9476357621629265-17-3
CYM 5541
UP291076450945128-26-7
NPS-2143
UP871519704284035-33-2
UM729
UP4296970811448723-60-1
Losartan
UP285336737114798-26-4
Cetilistat
UP712439682282526-98-1
SR-9243
UP4109682751613028-81-1
Captopril
UP58426076762571-86-2
SHP099 hydrochloride
UP4447479471801747-11-4
Gliclazide
UP75441803221187-98-4
1-[2-(Benzyloxy)ethyl]-4-(hydroxydiphenylmethyl)-1-quinuclidinium Bromide
UP833085687869113-09-7
TCS 359
UP223036483301305-73-7
VX-702
UP306585437745833-23-2
Nastorazepide
UP865674726209219-38-5
alpha-Spinasterol
UP418546192481-18-5
CGP 37849
UP295801418127910-31-0
VTP-27999
UP155610902942142-51-0
GLPG1690
UP4552943521628260-79-6
DREADD agonist 21
UP20669228156296-18-5
PF-543 Citrate
UP3808949251415562-83-2
DB07268
UP538744494929007-72-7
GSK2245035 Maleate
UP5964942961325212-97-2
IDO-IN-6
UP1554800601402837-76-6
Histamine Dihydrochloride
UP13583264056-92-8
2-deoxy-D-Glucose
UP225160710154-17-6
Tolbutamide
UP21391108764-77-7
A939572
UP7592634071032229-33-6
Istaroxime hydrochloride
UP718409503374559-48-5
DGAT1 Inhibitor C9
UP9477570521137671-16-9
ZLN024
UP139138467723249-01-2
Carbidopa
UP86651755628860-95-9
Heparin sodium
UP1825921689041-08-1
Polyinosinic acid-polycytidylic acid
UP62669787024939-03-5
DMOG
UP60856097789464-63-1
Amentoflavone
UP3452468711617-53-4
CPA inhibitor
UP567471938223532-02-3
Esomeprazole Magnesium(Random Configuration)
UP321887994161973-10-0
Valsartan
UP863621216137862-53-4
Naringin
UP36250555810236-47-2
NSC 23766
UP836598848733767-34-5
AZD0865
UP263558218248919-64-4
CarbORev-5901
UP247989876104325-75-9
Histamine phosphate
UP97737949151-74-1
Linagliptin
UP686768730668270-12-0
ELN-441958
UP744917508913064-47-8
SEW2871
UP167042027256414-75-2
Salirasib
UP774914570162520-00-5
Rolipram
UP55613946661413-54-5
TLR2-IN-C29
UP856468528363600-92-4
Calcium folinate
UP9946130901492-18-8
Pasireotide L-aspartate
UP694227217396091-77-3
Cyclosporine A
UP41782229459865-13-3
(-)-p-Bromotetramisole oxalate
UP58832509762284-79-1
Acefylline
UP734078845652-37-9
BQU57
UP7639556361637739-82-2
MRS1477
UP494495515212200-21-0